Literature DB >> 6310831

Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury.

O Sikujara, M Monden, K Toyoshima, J Okamura, G Kosaki.   

Abstract

The protective effect of prostaglandin I2 (PGI2) on ischemia-induced liver cell injury was investigated during 60-min, 75-min, and 90-min liver ischemia. Vehicle-treated rats tolerated the 75-min hepatic ischemia poorly. Only 25% of the rats in this group survived more than 7 days. However, the survival rate of PGI2-treated rats (350 ng/kg/min) significantly improved to 67%. Liver cell organelles were well-preserved by the PGI2 treatment. Adenosine triphosphate levels in the liver of the PGI2-treated rats were significantly higher than those of vehicle-treated rats at 60 min of reoxygenation following 75-min ischemia. Cyclic 3'-5' adenosine monophosphate levels markedly increased during 60-min PGI2 infusion. Cyclic 3'-5' guanosine monophosphate levels also significantly increased during the PGI2 infusion and were still higher than those of vehicle-treated rats at the end of the 75-min ischemia. Although the exact cytoprotective mechanism of PGI2 at the cellular level is still unclear, our results demonstrate that elevated ATP and cyclic nucleotides levels play an important role in liver cell preservation during ischemia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310831     DOI: 10.1097/00007890-198309000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

1.  Beneficial effects of administering intraportal prostaglandin E1 postoperatively to hepatectomy patients with massive intraoperative blood loss.

Authors:  T Katsuramaki; M Mukaiya; K Yamashiro; H Kimura; R Denno; K Hirata
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 2.  The therapeutic value of vasodilator prostaglandins in multiple organ failure associated with sepsis.

Authors:  D J Bihari; J Tinker
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  Effect of administration of fibronectin or aprotinin on liver regeneration after experimental hepatectomy.

Authors:  A H Kwon; S Uetsuji; M Yamamura; K Hioki; M Yamamoto
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

4.  Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.

Authors:  S Takaya; H Doyle; S Todo; W Irish; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-04       Impact factor: 1.066

Review 5.  Cell biology of liver endothelial and Kupffer cells.

Authors:  B Smedsrød; P J De Bleser; F Braet; P Lovisetti; K Vanderkerken; E Wisse; A Geerts
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

6.  A simple experimental model of total hepatectomy, hepatic ischemia and extrahepatic portal obstruction in rats using splenic transposition.

Authors:  S Omokawa; Y Arai; H Saito; T Furuya; T Sato; T Sato; K Shirayama; M Ito; Y Asanuma; K Koyama
Journal:  Jpn J Surg       Date:  1991-01

7.  Amelioration of normothermic canine liver ischemia with prostacyclin.

Authors:  S Todo; H Yokoi; L Podesta; P ChapChap; C Pan; K Okuda; Y Kamiyama; J Demetris; L Makowka; S Iwatsuki
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

8.  Metabolism of prostaglandins in porcine liver transplantation with a graft harvested after 30- and 60-minute warm ischemia.

Authors:  H Isai; J Kimura; K Ito; M Tamura; H Kon; H Kamachi; M Takahashi; K Yamashita; T Shimamura; Y Nakajima
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

9.  The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice.

Authors:  T Takahashi
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

10.  Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.

Authors:  E Totsuka; S Todo; Y Zhu; N Ishizaki; Y Kawashima; M B Jin; A Urakami; T Shimamura; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-09       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.